Sanara Current Deferred Revenue vs Long Term Debt Analysis

SMTI Stock

USD 35.91 0.71 1.94%

Sanara Medtech financial indicator trend analysis is much more than just breaking down Sanara Medtech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sanara Medtech is a good investment. Please check the relationship between Sanara Medtech Current Deferred Revenue and its Long Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

Current Deferred Revenue vs Long Term Debt

Current Deferred Revenue vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sanara Medtech Current Deferred Revenue account and Long Term Debt. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Sanara Medtech's Current Deferred Revenue and Long Term Debt is 0.8. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Sanara Medtech, assuming nothing else is changed. The correlation between historical values of Sanara Medtech's Current Deferred Revenue and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Sanara Medtech are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Current Deferred Revenue i.e., Sanara Medtech's Current Deferred Revenue and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.8

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Long Term Debt

Long-term debt is a debt that Sanara Medtech has held for over one year. Long-term debt appears on Sanara Medtech balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Sanara Medtech balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Sanara Medtech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sanara Medtech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.As of now, Sanara Medtech's Selling General Administrative is increasing as compared to previous years. Tax Provision is expected to grow at the current pace this year, while Issuance Of Capital Stock is projected to decrease to under 982.1 K.

	2021	2022	2023	2024 (projected)
Total Revenue	24.1M	45.8M	65.0M	68.2M
Interest Expense	711.0	284.7K	475.8K	499.6K

Total Revenue Interest Expense

Sanara Medtech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Inventory	Common Stock Total Equity	Property Plant And Equipment Gross	Current Deferred Revenue
Total Assets		0.76	0.95	0.94	0.99	0.98	-0.02	0.26	0.97	0.58	0.98	-0.86	0.58	0.99	0.92	0.9	0.8	0.7	0.95	0.9	-0.07	-0.58	0.99	-0.53	0.99	0.75
Short Long Term Debt Total	0.76		0.66	0.72	0.67	0.74	0.54	-0.01	0.83	0.09	0.83	-0.36	0.09	0.77	0.56	0.94	0.26	0.61	0.87	0.49	0.17	-0.32	0.8	-0.28	0.78	0.51
Other Current Liab	0.95	0.66		0.98	0.92	0.91	-0.03	0.28	0.89	0.52	0.93	-0.85	0.52	0.95	0.86	0.82	0.8	0.63	0.94	0.84	-0.08	-0.64	0.93	-0.58	0.92	0.77
Total Current Liabilities	0.94	0.72	0.98		0.89	0.89	0.08	0.19	0.91	0.43	0.94	-0.82	0.43	0.94	0.81	0.85	0.72	0.69	0.96	0.79	0.1	-0.63	0.93	-0.58	0.91	0.75
Total Stockholder Equity	0.99	0.67	0.92	0.89		0.98	-0.16	0.32	0.94	0.68	0.95	-0.88	0.68	0.96	0.95	0.83	0.86	0.66	0.9	0.95	-0.13	-0.59	0.97	-0.54	0.98	0.75
Property Plant And Equipment Net	0.98	0.74	0.91	0.89	0.98		-0.07	0.39	0.95	0.63	0.94	-0.8	0.63	0.96	0.96	0.85	0.83	0.59	0.91	0.92	-0.13	-0.66	0.97	-0.61	1.0	0.82
Net Debt	-0.02	0.54	-0.03	0.08	-0.16	-0.07		-0.38	0.16	-0.79	0.16	0.27	-0.79	0.08	-0.22	0.4	-0.49	0.16	0.25	-0.44	0.36	0.25	0.06	0.23	-0.01	-0.19
Retained Earnings	0.26	-0.01	0.28	0.19	0.32	0.39	-0.38		0.26	0.45	0.18	-0.29	0.45	0.28	0.39	0.09	0.46	-0.48	0.15	0.42	-0.32	-0.69	0.22	-0.77	0.32	0.54
Accounts Payable	0.97	0.83	0.89	0.91	0.94	0.95	0.16	0.26		0.41	0.99	-0.8	0.41	0.98	0.87	0.95	0.71	0.66	0.96	0.8	0.02	-0.57	0.98	-0.54	0.97	0.71
Cash	0.58	0.09	0.52	0.43	0.68	0.63	-0.79	0.45	0.41		0.41	-0.58	1.0	0.47	0.68	0.22	0.77	0.25	0.35	0.87	-0.3	-0.53	0.51	-0.48	0.59	0.59
Non Current Assets Total	0.98	0.83	0.93	0.94	0.95	0.94	0.16	0.18	0.99	0.41		-0.82	0.41	0.99	0.87	0.95	0.71	0.72	0.99	0.8	0.0	-0.51	0.99	-0.47	0.97	0.69
Non Currrent Assets Other	-0.86	-0.36	-0.85	-0.82	-0.88	-0.8	0.27	-0.29	-0.8	-0.58	-0.82		-0.58	-0.85	-0.84	-0.62	-0.89	-0.59	-0.75	-0.83	0.11	0.55	-0.83	0.5	-0.8	-0.65
Cash And Short Term Investments	0.58	0.09	0.52	0.43	0.68	0.63	-0.79	0.45	0.41	1.0	0.41	-0.58		0.47	0.68	0.22	0.77	0.25	0.35	0.87	-0.3	-0.53	0.51	-0.48	0.59	0.59
Net Receivables	0.99	0.77	0.95	0.94	0.96	0.96	0.08	0.28	0.98	0.47	0.99	-0.85	0.47		0.91	0.92	0.77	0.67	0.97	0.84	-0.07	-0.6	0.99	-0.55	0.98	0.74
Common Stock Shares Outstanding	0.92	0.56	0.86	0.81	0.95	0.96	-0.22	0.39	0.87	0.68	0.87	-0.84	0.68	0.91		0.72	0.92	0.57	0.8	0.92	-0.23	-0.6	0.92	-0.54	0.94	0.77
Non Current Liabilities Total	0.9	0.94	0.82	0.85	0.83	0.85	0.4	0.09	0.95	0.22	0.95	-0.62	0.22	0.92	0.72		0.48	0.67	0.96	0.64	0.05	-0.4	0.92	-0.37	0.89	0.57
Other Current Assets	0.8	0.26	0.8	0.72	0.86	0.83	-0.49	0.46	0.71	0.77	0.71	-0.89	0.77	0.77	0.92	0.48		0.45	0.63	0.9	-0.28	-0.66	0.77	-0.6	0.8	0.76
Other Stockholder Equity	0.7	0.61	0.63	0.69	0.66	0.59	0.16	-0.48	0.66	0.25	0.72	-0.59	0.25	0.67	0.57	0.67	0.45		0.71	0.53	0.21	-0.07	0.72	0.03	0.64	0.27
Total Liab	0.95	0.87	0.94	0.96	0.9	0.91	0.25	0.15	0.96	0.35	0.99	-0.75	0.35	0.97	0.8	0.96	0.63	0.71		0.75	0.05	-0.53	0.96	-0.48	0.94	0.71
Total Current Assets	0.9	0.49	0.84	0.79	0.95	0.92	-0.44	0.42	0.8	0.87	0.8	-0.83	0.87	0.84	0.92	0.64	0.9	0.53	0.75		-0.21	-0.66	0.86	-0.6	0.9	0.78
Short Term Debt	-0.07	0.17	-0.08	0.1	-0.13	-0.13	0.36	-0.32	0.02	-0.3	0.0	0.11	-0.3	-0.07	-0.23	0.05	-0.28	0.21	0.05	-0.21		-0.03	-0.04	-0.05	-0.09	-0.13
Common Stock	-0.58	-0.32	-0.64	-0.63	-0.59	-0.66	0.25	-0.69	-0.57	-0.53	-0.51	0.55	-0.53	-0.6	-0.6	-0.4	-0.66	-0.07	-0.53	-0.66	-0.03		-0.56	0.98	-0.62	-0.86
Inventory	0.99	0.8	0.93	0.93	0.97	0.97	0.06	0.22	0.98	0.51	0.99	-0.83	0.51	0.99	0.92	0.92	0.77	0.72	0.96	0.86	-0.04	-0.56		-0.5	0.99	0.74
Common Stock Total Equity	-0.53	-0.28	-0.58	-0.58	-0.54	-0.61	0.23	-0.77	-0.54	-0.48	-0.47	0.5	-0.48	-0.55	-0.54	-0.37	-0.6	0.03	-0.48	-0.6	-0.05	0.98	-0.5		-0.57	-0.77
Property Plant And Equipment Gross	0.99	0.78	0.92	0.91	0.98	1.0	-0.01	0.32	0.97	0.59	0.97	-0.8	0.59	0.98	0.94	0.89	0.8	0.64	0.94	0.9	-0.09	-0.62	0.99	-0.57		0.79
Current Deferred Revenue	0.75	0.51	0.77	0.75	0.75	0.82	-0.19	0.54	0.71	0.59	0.69	-0.65	0.59	0.74	0.77	0.57	0.76	0.27	0.71	0.78	-0.13	-0.86	0.74	-0.77	0.79

Click cells to compare fundamentals

Sanara Medtech Account Relationship Matchups

Sanara Medtech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.1M	9.8M	36.4M	61.0M	73.9M	77.6M
Short Long Term Debt Total	2.1M	481.4K	425.4K	819.2K	11.8M	12.4M
Other Current Liab	2.2M	2.8M	5.0M	10.8M	10.5M	11.0M
Total Current Liabilities	2.6M	3.5M	6.0M	12.8M	13.8M	14.5M
Total Stockholder Equity	6.6M	6.2M	30.6M	41.8M	44.8M	47.1M
Property Plant And Equipment Net	790.2K	1.1M	2.0M	2.2M	3.3M	3.4M
Net Debt	(4.5M)	26.0K	(18.2M)	(8.1M)	6.6M	7.0M
Retained Earnings	(2.7M)	(7.0M)	(15.2M)	(23.4M)	(28.0M)	(29.4M)
Accounts Payable	337.5K	494.8K	594.0K	1.4M	2.0M	2.1M
Cash	6.6M	455.4K	18.7M	9.0M	5.1M	5.4M
Non Current Assets Total	2.3M	5.3M	11.8M	40.4M	54.9M	57.6M
Non Currrent Assets Other	(2.3M)	(5.3M)	(11.8M)	(40.4M)	(19.0M)	(18.1M)
Cash And Short Term Investments	6.6M	455.4K	18.7M	9.0M	5.1M	5.4M
Net Receivables	1.3M	2.3M	3.0M	7.0M	8.5M	9.0M
Common Stock Shares Outstanding	2.1M	5.7M	7.3M	7.9M	8.3M	8.7M
Liabilities And Stockholders Equity	11.1M	9.8M	36.4M	61.0M	73.9M	77.6M
Non Current Liabilities Total	2.1M	446.1K	222.2K	6.5M	15.5M	16.3M
Other Current Assets	161.9K	611.8K	917.3K	1.1M	608.4K	638.8K
Other Stockholder Equity	(2.1M)	13.2M	45.9M	65.2M	72.9M	76.5M
Total Liab	4.7M	4.0M	6.2M	19.3M	29.3M	30.7M
Total Current Assets	8.9M	4.5M	24.6M	20.6M	19.0M	20.0M
Short Term Debt	117.5K	251.2K	406.6K	627.9K	1.3M	762.3K
Common Stock	3.6K	6.3K	7.7K	8.3K	8.5K	8.1K
Inventory	746.5K	1.1M	2.0M	3.5M	4.7M	5.0M
Common Stock Total Equity	236.6K	3.6K	6.3K	8.3K	9.5K	9.1K
Property Plant And Equipment Gross	790.2K	1.1M	2.4M	3.0M	4.4M	4.7M
Intangible Assets	1.5M	3.1M	4.7M	31.5M	44.9M	47.2M
Net Tangible Assets	(6.2M)	3.1M	25.9M	6.7M	7.7M	8.1M
Property Plant Equipment	790.2K	1.1M	2.0M	1.4M	1.6M	1.7M
Net Invested Capital	(3.3M)	6.2M	30.6M	41.8M	54.5M	57.3M
Net Working Capital	6.2M	942.4K	18.6M	7.8M	5.2M	6.2M
Capital Stock	11.4M	6.3K	7.7K	8.3K	8.5K	8.1K

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Sanara Medtech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanara Medtech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanara Medtech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanara Medtech Stock:

How To Invest In Sanara

Details

Is Sanara Stock a good investment?

Details

What is Sanara Medtech's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sanara Medtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanara Medtech. If investors know Sanara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanara Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.99)

Revenue Per Share

9.241

Quarterly Revenue Growth

0.352

Return On Assets

(0.05)

Return On Equity

(0.20)

The market value of Sanara Medtech is measured differently than its book value, which is the value of Sanara that is recorded on the company's balance sheet. Investors also form their own opinion of Sanara Medtech's value that differs from its market value or its book value, called intrinsic value, which is Sanara Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanara Medtech's market value can be influenced by many factors that don't directly affect Sanara Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sanara Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanara Medtech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanara Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanara Current Deferred Revenue vs Long Term Debt Analysis

Current Deferred Revenue vs Long Term Debt

Current Deferred Revenue vs Long Term Debt Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Long Term Debt

Sanara Medtech fundamental ratios Correlations

Sanara Medtech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sanara Medtech fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Net Receivables	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Property Plant And Equipment Gross	+ 0.99	Total Assets

Other Current Assets	- 0.89	Non Currrent Assets Other
Non Currrent Assets Other	- 0.88	Total Stockholder Equity
Current Deferred Revenue	- 0.86	Common Stock
Non Currrent Assets Other	- 0.86	Total Assets
Net Receivables	- 0.85	Non Currrent Assets Other
Non Currrent Assets Other	- 0.85	Other Current Liab